Spain > Legal Developments > EU & Competition
Search News and Articles
REORGANIZATIONS OF BIOTECH FIRMS
In spite of the M&A downturn both globally and in the healthcare industry in particular, 2008 saw a twofold increase in the volume of deals involving biotech firms. Judging from the news that emerged during 2009 and in light of recent surveys, this trend looks set to continue and the outlook is undoubtedly rosy, above all in pharmaceutical R&D.